AstraZeneca Admits Vaxzevria COVID Vaccine Can Cause Fatal Side Effects
AstraZeneca plc, the largest and most profitable pharmaceutical company in the United Kindgdom1 has admitted in court documents that its COVID-19 vaccine, Vaxzevria, which was developed in partnership with the University of Oxford, can cause the blood disorder thrombosis with thrombocytopenia syndrome (TTS) in “very rare cases.” TTS is an immune disorder specifically associated with […]
FDA Proposes Banning Food Additive BVO
Following California’s lead, the U.S. Food and Drug Administration (FDA) has proposed to ban the food additive brominated vegetable oil (BVO). Toxicology studies conducted in collaboration with the U.S. National Institutes of Health (NIH) led to the FDA concluding that BVO is “no longer safe” due largely in part to its ability to harm thyroid […]
U.S. Government is Funding Gain-of-Function Research in China to Make Bird Flu More Infectious
The U.S government is again funding gain-of-function (GoF) research with Chinese scientists to make a dangerous virus even more potent. This time it is with birds not bats. The U.S. Department of Agriculture (USDA) gave $1 million to fund risky research on bird flu viruses to the Chinese Academy of Sciences in Beijing, China; the […]
FDA Adds Boxed Warning to Merck’s Asthma Drug Singulair About Suicide, Neuropsychiatric Side Effects
In 2008, the FDA issued a warning advising that it would investigate a possible risk of suicide associated with Merck & Co.’s asthma and allergy drug Singulair after there were many reports of increases in agitation, aggression, anxiety, depression and suicidal thoughts. Hallucinations also were documented for children and adolescents taking Singulair. When the drug’s […]
BARDA Awards $9.27 Million Contract to Evaluate Oral Pill COVID Vaccine
Biotechnology firm Vaxart, Inc. announced on Jan. 19, 2024 that it received a $9.27 million contract from the U.S. Biomedical Advanced Research and Development Authority (BARDA) to fund preparations for a Phase IIb clinical trial to evaluate the company’s oral pill XXB COVID-19 vaccine candidate. The trial is expected to involve 10,000 participants and will […]
Evidence of Alarming Growth in Cognitive Impairment Among Adults
According to research conducted in Netherlands by the Network for Health Research in Disasters (GOR Network), a significant number of adults are increasingly grappling with unexplained memory and concentration problems. The findings show an alarming 24 percent spike in doctor visits related to cognitive impairment issues among people 25 years and older during the first […]